Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2020.03.03
2020年面向合格投资者公开发行公司债券（疫情防控债）在深圳证券交易所上市的公告
2020.02.29
2019年度业绩快报
2020.02.28
2020年面向合格投资者公开发行公司债券（疫情防控债）发行结果公告
2020.02.28
2020年第一次临时股东大会决议公告
2020.02.28
2020年第一次临时股东大会的法律意见书
2020.02.28
第四届董事会第三十次会议决议公告
2020.02.26
2020年面向合格投资者公开发行公司债券（疫情防控债）票面利率公告
2020.02.26
2020年面向合格投资者公开发行公司债券（疫情防控债）发行相关情况的调整公告
2020.02.26
2020年面向合格投资者公开发行公司债券（疫情防控债）发行相关情况的调整公告
2020.02.25
2020年公开发行公司债券信用评级报告
第一页
上一页
41
42
43
44
45
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Industrial Chain
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
